Skip to main content
logo
Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
34.41
+1.54 (4.69%)
Aug 4, 2026, 4:00 PM EDT - Market closed

Neurogene Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.93---
Revenue Growth
------
Gross Profit
--0.93---
Operating Income
-110.76-103.33-82.61-55.58-56.52-60.7
Net Income
-98.64-90.35-75.14-36.32-55.19-60.69
Earnings Per Share
-4.56-4.24-4.28-27.76-139.88-22.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
243.18269.01312.41197.16130.97142.47
Total Debt
9.139.8912.4314.974.6912.98
Net Cash (Debt)
234.05259.12299.98182.19126.28129.48
Net Cash Growth
-16.68%-13.62%64.65%44.27%-2.47%-28.24%
Net Cash Per Share
10.8112.1517.0839.1245.8847.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-82.52-77.17-70.6-51.42-52.82-47.56
Capital Expenditures
-0.68-1.18-0.81-0.32-2.23-3.26
Free Cash Flow
-83.2-78.36-71.41-51.74-55.05-50.82
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%---
Operating Margin
---8930.27%---
Pretax Margin
---8123.68%---
Profit Margin
---8123.68%---
FCF Margin
---7720.11%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--367.11---